Differences in Adiponectin Protein Expression: Effect of Fat Depots and Type 2 Diabetic Status

 

 Buy Article Permissions and Reprints

Abstract

Adiponectin is an adipocyte-derived hormone associated with insulin sensitivity and atherosclerotic risk. As central rather than gluteofemoral fat is known to increase the risk of type 2 diabetes and cardiovascular disease, we investigated the mRNA and protein expression of adiponectin in human adipose tissue depots. RNA was extracted from 46 human adipose tissue samples from non-diabetic subjects aged 44.33 ± 12.4 with a BMI of 28.3 ± 6.0 (mean ± SD). The samples were as follows: 21 abdominal subcutaneous, 13 omentum, 6 thigh; samples were also taken from diabetic subjects aged 66.6 ± 7.5 with BMI 28.9 ± 3.17; samples were: 6 abdominal subcutaneous; 3 thigh. Quantitative PCR and Western analysis was used to determine adiponectin content. Protein content studies determined that when compared with non-diabetic abdominal subcutaneous adipose tissue (Abd Sc AT) (values expressed as percentage relative to Abd Sc AT -100 %). Adiponectin protein content was significantly lower in non-diabetic omental AT (25 ± 1.6 %; p < 0.0001, n = 6) and in Abd Sc AT from diabetic subjects (36 ± 1.5 %; p < 0.0001, n = 4). In contrast, gluteal fat maintained high adiponectin protein content from non-diabetic patients compared with diabetic patients. An increase in BMI was associated with lower adiponectin protein content in obese ND Abd Sc AT (25 ± 0.4 %; p < 0.0001). These findings were in agreement with the mRNA expression data. In summary, this study indicates that adiponectin protein content in non-diabetic subjects remains high in abdominal subcutaneous fat, including gluteal fat, explaining the high serum adiponectin levels in these subjects. Omental fat, however, expresses little adiponectin. Furthermore, abdominal and gluteal subcutaneous fat appears to express significantly less adiponectin once diabetic status is reached. In conclusion, the adipose tissue depot-specific expression of adiponectin may influence the pattern of serum adiponectin concentrations and subsequent disease risk.

References

• 1 Haffner S M, Karhappa P, Mykkanen L, Laasko M. Insulin resistance, body fat distrubtion, and sex hormones in men.  Diabetes. 1994;  43 212-219
  CrossrefPubMedGoogle Scholar
• 2 Despres J P, Moorjani S, Luipen P J, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.  Arteriosclerosis. 1990;  10 497-511
  PubMedGoogle Scholar
• 3 Matthaei S, Stumvoll M, Kellerer M, Haring H U. Pathophysiology and pharmacological treatment of insulin resistance.  Endocr Rev. 2000;  21 585-618
  CrossrefPubMedGoogle Scholar
• 4 Spiegelman B M, Flier J S. Obesity and the regulation of energy balance.  Cell. 2001;  104 531-543
  CrossrefPubMedGoogle Scholar
• 5 Kappes A, Loffler G. Influences of Ionomycin, dibutyryl-cycloAMP and tumour necrosis factors-alpha on intracellular amount of secretion of apM1 in differentiating primary human preadipocytes.  Horm Metab Res. 2000;  32 548-554
  PubMedGoogle Scholar
• 6 Saltiel A R, Kahn C R. Insulin signalling and the regulation of glucose and lipid metabolism.  Nature. 2001;  414 799-806
  CrossrefPubMedGoogle Scholar
• 7 Bastelica D, Morange P, Berhet B, Borghi H, Lacroix O, Grino M, Juhan-Vague I, Alessi M C. Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits.  Arterioscler Thromb Vasc Biol. 2002;  22 173-178
  CrossrefPubMedGoogle Scholar
• 8 Hotamisligil G S, Arner P, Caro J F, Atkinson R L, Spiegelman B M. Increased adipose tissue expression of tumor necrosis factor α in human obesity and insulin resistance.  J Clin Invest. 1995;  95 2409-2415
  CrossrefPubMedGoogle Scholar
• 9 Freidman J M, Halaas J L. Leptin and the regulation of body weight in mammals.  Nature. 1998;  395 763-770
  CrossrefPubMedGoogle Scholar
• 10 Folli F, Kahn C R, Hansen H, Bouchie J L, Feener E P. Angiotensin II inhibits insulin signalling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk.  J Clin Invest. 1997;  100 2158-2169
  CrossrefPubMedGoogle Scholar
• 11 Steppan C M, Bailey S T, Bhat S, Brown E J, Banerjee R R, Wright C M, Patel H R, Ahima R S, Lazar M A. The hormone resistin links obesity to diabetes.  Nature. 2001;  409 307-312
  CrossrefPubMedGoogle Scholar
• 12 Berg A H, Combs T P, Scherer P E. ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism.  Trends Endocrinol Metab. 2002;  13 84-89
  CrossrefPubMedGoogle Scholar
• 13 Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (Adipose Most abundant gene Transcript 1).  Biochem Biophys Res Commun. 1996;  221 286-289
  CrossrefPubMedGoogle Scholar
• 14 Shapiro L, Scherer P E. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor.  Curr Biol. 1998;  8 335-338
  CrossrefPubMedGoogle Scholar
• 15 Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahasi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Murguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanfusa T, Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.  Arterioscler Thromb Vas Biol. 2000;  20 1595-1599
  CrossrefPubMedGoogle Scholar
• 16 Lindsay R S, Funahashi T, Hanson R L, Matsuzawa Y, Tanaka S, Tataranni P A, Knowler W C, Krakoff J. Adiponectin and development of type 2 diabetes in the Pima Indian population.  Lancet. 2002;  360 57-58
  CrossrefPubMedGoogle Scholar
• 17 Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyako K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.  Biochem Biophys Res Commun. 1999;  257 79-83
  CrossrefPubMedGoogle Scholar
• 18 Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.  Circulation. 1999;  100 2473-2476
  CrossrefPubMedGoogle Scholar
• 19 Okamoto Y, Artia Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M, Igura T, Inui Y, Kihara S, Nakamura T, Yamashita S, Miyagawa J, Funahashi T, Matsuzawa Y. An adipocyte-derived plasma protein adiponectin adheres to injured vascular walls.  Horm Metab Res. 2000;  32 47-50
  Article in Thieme ConnectPubMedGoogle Scholar
• 20 Fruebis J, Tsao T S, Javorschi S, Ebbts-Reed D, Erickson M R, Yen F T, Bihain B E, Lodish H F. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice.  Proc Natl Acad Sci USA. 2001;  98 2005-2010
  CrossrefPubMedGoogle Scholar
• 21 Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota H, Hara K, Mori Y, Ide T, Murakami K, Tsubiyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Retman M L, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipotrophy and obesity.  Nat Med. 2001;  7 941-946
  CrossrefPubMedGoogle Scholar
• 22 Berg A H, Combs T P, Du X, Brownless M, Scherer P E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.  Nat Med. 2001;  7 947-953
  CrossrefPubMedGoogle Scholar
• 23 Combs T P, Berg A H, Obici S, Scherer P E, Rossetti L J. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30.  Clin Invest. 2001;  108 1875-1881
  CrossrefPubMedGoogle Scholar
• 24 Scherer P E, Williams S, Fogliano M, Baldini G, Lodish H F. A novel serum protein similar to Clq, produced exclusively in adipocytes.  J Biol Chem. 1995;  270 26746-26749
  CrossrefPubMedGoogle Scholar
• 25 Nakano Y, Tobe T, Choi-Miura N H, Mazda T, Tomita M. Isolation and characterisation of GBP28, a novel gelatain-binding protein purified from human plasma.  J Biochem. 1996;  120 803-812
  CrossrefPubMedGoogle Scholar
• 26 Statnick M A, Beavers L S, Conner L J, Corominola H, Johnson D, Hammond C D, Rafaeloff-Phail R, Seng T, Suter T M, Sluka J P, Ravussin E, Gadski R A, Caro J F. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes.  Int J Exp Diabetes Res. 2000;  1 81-88
  CrossrefPubMedGoogle Scholar
• 27 Halleux C M, Takahashi M, Delporte M L, Detry R, Funahashi T, Matsuzawa Y, Brichard S M. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue.  Biochem Bipohys Res Comm. 2001;  288 1102-1107
  CrossrefPubMedGoogle Scholar
• 28 McTernan P G, McTernan C L, Chetty R, Jenner K, Fisher f M, Lauer M N, Crocker J, Barnett A H, Kumar S. Increased resistin gene and protein expression in human abdominal adipose tissue.  J Clin Endocrinol Metab. 2002;  87 2407-2410
  CrossrefPubMedGoogle Scholar
• 29 Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utlising the principle of protein-dye binding.  Anal Biochem. 1976;  72 807-811
  PubMedGoogle Scholar
• 30 McTernan P G, Sheppard M C, Williams G R. Hormone-induced changes in nuclear receptor stoichiometry in HL60 cells correlate with induction of monocyte or neutrophil differentiation.  J Endocrinol. 1998;  156 135-148
  CrossrefPubMedGoogle Scholar
• 31 McTernan P G, Harte A L, Anderson L A, Green A, Holder J, Smith S A, Barnett A H, Eggo M, Kumar S. Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro.  Diabetes. 2002;  51 1493-1498
  PubMedGoogle Scholar
• 32 McTernan C L, McTernan P G, Harte A L, Levick P, Barnett A H, Kumar S. Resistin-The link between central obesity and type 2 diabetes.  Lancet. 2002;  35 46-47
  PubMedGoogle Scholar
• 33 Maeda N, Takahashi M, Funahashi T, Kihara S, Nishzawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein.  Diabetes. 2001;  50 2904-2909
  PubMedGoogle Scholar
• 34 Kissebath A H, Sonnenberg G E, Myklebust J, Goldstein M, Broman K, James R G, Marks J A, Krakower G R, Jocob H J, Weber J, Martin L, Blangero J, Commuzzie A G. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome.  Proc Natl Acad Sci USA. 2001;  97 14 478-14 483
  PubMedGoogle Scholar
• 35 Kondo H, Shimoura I, Matsukawa Y, Kumada M, Takahashi M, Matsuda M, Ouchi N, Kihara S, Kawamoto T, Sumitsuji S, Funahashi T, Matsuzawa Y. Association of adiponectin mutation with type 2 diabetes. A candidate gene for the insulin resistance syndrome.  Diabetes. 2002;  50 2325-2328
  PubMedGoogle Scholar
• 36 Hu E, Liang P, Spiegelman B M. AdipoQ is a novel adipose-specific gene dysregulated in obesity.  J Biol Chem. 2002;  271 10 697-10 703
  PubMedGoogle Scholar
• 37 Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay R S, Youngren J F, Havel P J, Prately R E, Bogardus C, Tataranni P A. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans.  Diabetes. 2002;  50 1884-1888
  PubMedGoogle Scholar
• 38 Depres J P, Moorjani S, Luipen P J, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.  Arteriosclerosis. 1990;  10 497-511
  PubMedGoogle Scholar

Dr. P. G. McTernan

Division of Medical Sciences · Department of Medicine

Clinical Research Block · Queen Elizabeth Hospital · Edgbaston, Birmingham B15 2TH · UK ·

Phone: + 44 (121) 472 1311, Ext. 3918 ·

Fax: + 44 (121) 414 7610

Email: p.g.mcternan.20@bham.ac.uk